TABLE 8.
Metabolite name | Fold change (FC)* |
Myristate (14:0) | 1.40# |
Pentadecanoate (15:0) | 1.22∧ |
Palmitate (16:0) | 1.48# |
Palmitoleate (16:1 n-7) | 1.40∧ |
Margarate (17:0) | 1.50# |
10-heptadecenoate (17:1 n-7) | 1.34∧ |
Stearate (18:0) | 1.31# |
Oleate/vaccenate (18:1) | 1.61# |
Nonadecanoate (19:0) | 1.37∧ |
10-nonadecenoate (19:1 n-9) | 1.44∧ |
Arachidate (20:0) | 1.20∧ |
Eicosenoate (20:1) | 1.36∧ |
Erucate (22:1 n-9) | 1.48# |
Nervonate (24:1 n-9) | 1.46# |
Eicosapentaenoate (EPA; 20:5 n-3) | 2.68# |
Docosapentaenoate (n-3 DPA; 22:5 n-3) | 1.86# |
Docosahexaenoate (DHA; 22:6 n-3) | 1.99# |
Linoleate (18:2 n-6) | 2.48# |
Linolenate (18:3 n-3 or n-6) | 2.14# |
Dihomo-linolinate (20:3 n-3 or n-6) | 2.05# |
Arachidonate (20:4 n-6) | 2.61# |
n-6 DPA (22:5 n-6) | 2.77# |
Docosadienoate (22:2 n-6) | 1.97# |
Dihomo-linoleate (20:2 n-6) | 2.02# |
Mead acid (20:3 n-9) | 3.03# |
*Fold change values normalized to the pre-exercise time point in the unconditioned state. ∧0.05 < p < 0.1; q < 0.1, trend for statistical significance. #p < 0.05; q < 0.1, statistically significant fold change relative to the unconditioned state.